Effects of HER2-Binding Affibody Molecules on Intracellular Signaling Pathways
Authors:
- Ann-Charlott SteffenASAnn-Charlott Steffen
- JÖRgen CarlssonJCJÖRgen Carlsson
- Johan LennartssonJLJohan Lennartsson
- 1 January 2006
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 27 (4) , 201-210
Abstract
Background: HER2, which is overexpressed in 25–30% of human breast cancers, is a tyrosine kinase receptor critical for the signal transduction network that regulates proliferation, migration and apoptosis of cells. Method: We report the effects of two novel HER2-binding affibody molecules (Affibody®), (ZHER2:4)2 and ZHER2:342, on intracellular signal transduction pathways (Erk1/2, Akt and PLCγ1) using quantitative immunoblotting techniques and their biological effects in cell culture. The clinically approved antibody trastuzumab (Herceptin®) was used as reference substance. Results: Our data showed that, although all substances target HER2, the effects on the receptor and signaling molecules differed. For example, HER2 phosphorylation was induced by trastuzumab and (ZHER2:4)2 but inhibited by ZHER2:342. The effects these substances had on signal transduction correlated to some degree with changes in growth and migration, e.g. (ZHER2:4)2 stimulated phosphorylation of Erk1/2 and PLCγ1, as well as growth and migration, while ZHER2:342 did not. ZHER2:342 even inhibited phosphorylation of PLCγ1 and migration. Conclusion: Our data suggest that ZHER2:342 is a promising small agent (7 kDa) that may be used as an alternative, or complement, to trastuzumab. If radiolabelled, it can hopefully also be used for HER2 imaging and radionuclide therapy.Keywords
This publication has 19 references indexed in Scilit:
- Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT SignalingJournal of Biological Chemistry, 2005
- Selection and characterization of HER2/neu-binding affibody ligandsProtein Engineering, Design and Selection, 2004
- Do phosphoinositide 3-kinases direct lymphocyte navigation?Trends in Immunology, 2004
- MAPK signal pathways in the regulation of cell proliferation in mammalian cellsCell Research, 2002
- Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing FunctionBiochemical and Biophysical Research Communications, 2001
- Induction of Apoptosis by Cancer ChemotherapyExperimental Cell Research, 2000
- Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivoNature Biotechnology, 2000
- Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos inductionOncogene, 1999
- Overactivation of Phospholipase C-γ1 Renders Platelet-derived Growth Factor β-Receptor-expressing Cells Independent of the Phosphatidylinositol 3-Kinase Pathway for ChemotaxisJournal of Biological Chemistry, 1999
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987